BridgeBio Oncology Therapeutics, Inc. - COMMON STOCK (BBOT)

CUSIP: 107924102

Q3 2025 13F Holders as of 30 Sep 2025

Security identity
Security type / class
Equity / COMMON STOCK
Shares outstanding
80,458,364
Holder snapshot
Total 13F shares
56,812,363
Share change
+56,812,363
Total reported value
$657,547,712
Reported price per share
$11.58
Number of holders
41
Value change
+$657,547,712
Number of buys
41

Security key

107924102

Report period

Q3 2025

Institutions

41

Top holders

10

BBOT full security history Ownership snapshot Full 13F holder table Newer quarter: Q4 2025 BridgeBio Oncology Therapeutics, Inc. SEC filings BridgeBio Oncology Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Ownership snapshot

Top reported holders of BBOT - BridgeBio Oncology Therapeutics, Inc. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
Helix Holdings II LLC
13D/G signal
Helix Holdings II LLC
Evidence rows
15
Latest as of
30 Sep 2025
13D/G 3/4/5 13F Lead comparable stake: 23% 13D/G row: Helix Holdings II LLC Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
Helix Holdings II LLC
13D/G 3/4/5
Bihua Chen · Director, 10%+ Owner
13D/G 3/4/5
23%
—
17,878,594 shares
 $0 11 Aug 2025
BridgeBio Pharma LLC
13D/G
13D/G
18%
—
13,878,554 shares
 $0 11 Aug 2025
BlackRock Portfolio Management LLC
13D/G
13D/G
7.9%
—
1,498,865 shares
 $0 31 Mar 2025
James E. Flynn
13D/G
Deerfield Management Company, L.P.
13D/G
6.2%
—
4,885,446 shares
 $0 11 Aug 2025
BC Global Opportunities IX LP
13D/G
13D/G
5.5%
$42,740,663
4,365,747 shares
 $0 04 Sep 2025
Sculptor Capital LP
13D/G 13F
Company
13D/G 13F
5.1%
$10,419,544
967,460 shares
 $0 17 Jul 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
41
Shares
56,812,363
Rows available
41
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q3 2025 vs Q4 2025 Across Filers

Q4 2025 holders
52
Q3 2025 holders
41
Holder diff
-11
Investor Q4 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q4 2025 value Q3 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .